Lineage Cell Therapeutics, Inc. · AMEX:LCTX
BlackRock, Inc. reported a 5.30% stake in Lineage Cell Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 5.30% stake in Lineage Cell Therapeutics, Inc., 13,185,489 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 13,185,489
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 13,185,489 |
Source
Related
- Lineage Cell Therapeutics, Inc.
- BlackRock, Inc.
- Lineage Cell Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G · BlackRock, Inc. · Apr 24, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13D/A · Neal C. Bradsher · Nov 14, 2025
- Schedule 13G · Chernett Jorey · Sep 26, 2025
- Schedule 13D/A · Neal C. Bradsher · Jan 28, 2025